This 2-stage randomized clinical trial compared lipid-lowering efficacy of 2 nonstatin therapies, ezetimibe and evolocumab, among patients with uncontrolled low-density lipoprotein cholesterol levels and intolerance to 2 or more statins.
This pharmacoepidemiology study uses NHANES data to describe trends in prescription drug use among US adults between 1999 and 2012.
To determine whether statin therapy can decrease day-28 mortality in patients with VAP, Papazian
and coauthors conducted a randomized, placebo-controlled, double-blind, parallel-group, multicenter
trial in 26 intensive care units in France from January 2010 to March 2013.
This Viewpoint discusses the benefits of statins and factors related to statin intolerance.
This study compares the cost-effectiveness of using various 10-year atherosclerotic cardiovascular disease risk thresholds for initiating statin therapy.
You currently have no searches saved.